{
    "id": 544,
    "fullName": "PDGFRA V561D",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "PDGFRA V561D lies within the juxtamembrane domain of the Pdgfra protein (PMID: 12949711). V561D confers a gain of function to the Pdgfra protein resulting in constitutive tyrosine phosphorylation in cell culture (PMID: 12949711) and demonstrates increased transformation ability in two different cell lines (PMID: 29533785).",
            "references": [
                {
                    "id": 2161,
                    "pubMedId": 12949711,
                    "title": "Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/12949711"
                },
                {
                    "id": 11238,
                    "pubMedId": 29533785,
                    "title": "Systematic Functional Annotation of Somatic Mutations in Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29533785"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5156,
        "geneSymbol": "PDGFRA",
        "terms": [
            "PDGFRA",
            "CD140A",
            "PDGFR-2",
            "PDGFR2"
        ]
    },
    "variant": "V561D",
    "createDate": "05/14/2014",
    "updateDate": "04/29/2018",
    "referenceTranscriptCoordinates": {
        "id": 119084,
        "transcript": "NM_006206",
        "gDna": "chr4:g.54274869T>A",
        "cDna": "c.1682T>A",
        "protein": "p.V561D",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 17884,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing PDGFRA V561D demonstrated sensitivity to Gleevec (imatinib) in culture, resulting in decreased cell proliferation (PMID: 30389923).",
            "molecularProfile": {
                "id": 603,
                "profileName": "PDGFRA V561D"
            },
            "therapy": {
                "id": 770,
                "therapyName": "Imatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 15855,
                    "pubMedId": 30389923,
                    "title": "Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30389923"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 191,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cells expressing PDGFRA V561D demonstrated sensitivity to Gleevec (imatinib) in cell culture (PMID: 15928335).",
            "molecularProfile": {
                "id": 603,
                "profileName": "PDGFRA V561D"
            },
            "therapy": {
                "id": 770,
                "therapyName": "Imatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 272,
                    "pubMedId": 15928335,
                    "title": "PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15928335"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 17885,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing PDGFRA V561D demonstrated sensitivity to GSK2126458 (omipalisib) in culture, resulting in decreased cell proliferation (PMID: 30389923).",
            "molecularProfile": {
                "id": 603,
                "profileName": "PDGFRA V561D"
            },
            "therapy": {
                "id": 763,
                "therapyName": "GSK2126458",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 15855,
                    "pubMedId": 30389923,
                    "title": "Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30389923"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 12307,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Ayvakit (avapritinib) inhibited Kit phosphorylation in transformed cells overexpressing PDGFRA V561D in culture (PMID: 29093181).",
            "molecularProfile": {
                "id": 603,
                "profileName": "PDGFRA V561D"
            },
            "therapy": {
                "id": 2941,
                "therapyName": "Avapritinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 10301,
                    "pubMedId": 29093181,
                    "title": "A precision therapy against cancers driven by KIT/PDGFRA mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29093181"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 17883,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing PDGFRA V561D demonstrated sensitivity to Sutent (sunitinib) in culture, resulting in decreased cell proliferation (PMID: 30389923).",
            "molecularProfile": {
                "id": 603,
                "profileName": "PDGFRA V561D"
            },
            "therapy": {
                "id": 930,
                "therapyName": "Sunitinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 15855,
                    "pubMedId": 30389923,
                    "title": "Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30389923"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 17881,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing PDGFRA V561D demonstrated sensitivity to Tasigna (nilotinib) in culture, resulting in decreased cell proliferation (PMID: 30389923).",
            "molecularProfile": {
                "id": 603,
                "profileName": "PDGFRA V561D"
            },
            "therapy": {
                "id": 829,
                "therapyName": "Nilotinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 15855,
                    "pubMedId": 30389923,
                    "title": "Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30389923"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 17882,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing PDGFRA V561D demonstrated sensitivity to Crenolanib in culture, resulting in decreased cell proliferation (PMID: 30389923).",
            "molecularProfile": {
                "id": 603,
                "profileName": "PDGFRA V561D"
            },
            "therapy": {
                "id": 705,
                "therapyName": "Crenolanib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 15855,
                    "pubMedId": 30389923,
                    "title": "Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30389923"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8936,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, PDGFRA D842V conferred resistance to inhibition of PDGFRA phosphorylation by Sutent (sunitinib) in cells expressing PDGFRA V561D in culture (PMID: 18955458).",
            "molecularProfile": {
                "id": 26542,
                "profileName": "PDGFRA V561D PDGFRA D842V"
            },
            "therapy": {
                "id": 930,
                "therapyName": "Sunitinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 3383,
                    "pubMedId": 18955458,
                    "title": "Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18955458"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 603,
            "profileName": "PDGFRA V561D",
            "profileTreatmentApproaches": [
                {
                    "id": 1274,
                    "name": "PDGFR-alpha Inhibitor",
                    "profileName": "PDGFRA V561D"
                },
                {
                    "id": 1273,
                    "name": "PDGFR Inhibitor (Pan)",
                    "profileName": "PDGFRA V561D"
                }
            ]
        },
        {
            "id": 26542,
            "profileName": "PDGFRA V561D PDGFRA D842V",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 119087,
            "transcript": "XM_017008282",
            "gDna": "chr4:g.54274869T>A",
            "cDna": "c.1682T>A",
            "protein": "p.V561D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 119088,
            "transcript": "XM_005265743",
            "gDna": "chr4:g.54274869T>A",
            "cDna": "c.1682T>A",
            "protein": "p.V561D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 119084,
            "transcript": "NM_006206",
            "gDna": "chr4:g.54274869T>A",
            "cDna": "c.1682T>A",
            "protein": "p.V561D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 119085,
            "transcript": "XM_006714041",
            "gDna": "chr4:g.54274579_54274580delTGinsAC",
            "cDna": "c.1682_1683delTGinsAC",
            "protein": "p.V561D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 119089,
            "transcript": "XM_011534385",
            "gDna": "chr4:g.54274869T>A",
            "cDna": "c.1682T>A",
            "protein": "p.V561D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 119086,
            "transcript": "XM_006714039",
            "gDna": "chr4:g.54274579_54274580delTGinsAC",
            "cDna": "c.1682_1683delTGinsAC",
            "protein": "p.V561D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}